EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieOpen Access · CC BY 4.0

Subanesthetic ketamine alters EEG signal complexity: Implications for treatment stratification in depression

Weng-Lam Chan, Sebastian Olbrich, Xinwen Jiang, Haoyun Zhang, Cheng-Teng Ip, Martin Brunovsky

Journal of Affective Disorders · 2025

DOI: 10.1016/j.jad.2025.119477 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Weng-Lam Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cognitive and Brain Sciences, University of Macau, Taipa, Macau. Hauptthemen laut MEDLINE: Brain, Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Electroencephalography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, National Natural Science Foundation of China, University of Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder, particularly its treatment-resistant form (TRD), poses significant treatment challenges. Ketamine, an N-methyl-d-aspartate receptor antagonist, has shown promise in rapidly alleviating depressive symptoms by influencing neuroplasticity and glutamatergic modulation, which are thought to influence brain activity complexity. In this placebo-controlled study, we examined the effects of subanesthetic doses of intravenous ketamine on EEG signal complexity in 24 MDD patients, 21 of whom had TRD. Treatment response was defined by a ≥ 33 % reduction in Montgomery-Åsberg Depression Rating Scale (MADRS) after ketamine administration. Patients underwent eyes-closed resting state EEG recording pre-, start-, end- and 24 h post-infusion, analyzed for temporospatial and spatiotemporal Lempel-Ziv complexity (LZCT and LZCS). Results indicated that ketamine significantly increased whole-brain LZCT during infusion compared to placebo (sodium chloride 0.9 %) (16.90 % vs. -4.84 %, 95 % CI 4.29 to 39.18, p = 0.017). Elevated LZCT at end-pre was associated with less short-term symptom improvement the following day. Conversely, lower pretreatment occipital LZCT (0.33 vs. 0.46, 95 % CI 0.007 to 0.26, p = 0.040) predicted a favorable response to ketamine, supported by a logistic regression model with an ROC area of 0.75. No significant changes were observed in LZCS, suggesting limited utility as a biomarker. In conclusion, occipital LZCT could serve as an effective predictive biomarker for ketamine's therapeutic effects in MDD, with implications for patients with TRD. This underscores the potential of EEG complexity measures in stratifying treatment and enhancing our understanding of the neural impacts of ketamine in depressive disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainMajor Depressive DisorderDepressive Disorder, Treatment-ResistantElectroencephalographyExcitatory Amino Acid AntagonistsKetamineAdultFemaleHumansMaleMiddle AgedDouble-Blind MethodTreatment Outcome

Stichwörter der Autor:innen

BiomarkerEEGKetamineLempel-Ziv complexityMDDTreatment response

Substanzen

Excitatory Amino Acid AntagonistsKetamine

Autor:innen und Institutionen

  • Centre for Cognitive and Brain Sciences, University of Macau, Taipa, Macau.
  • Hospital for Psychiatry, Psychotherapy and Psychosomatic; University Zurich, Zurich, Switzerland.
  • Centre for Cognitive and Brain Sciences, University of Macau, Taipa, Macau; Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Taipa, Macau. Electronic address: ch…
  • National Institute of Mental Health, Klecany, Czech Republic; Charles University, Third Faculty of Medicine, Prague, Czech Republic.

Förderung

  • European Regional Development Fund
  • National Natural Science Foundation of China
  • University of Macau
  • Ministry of Health of the Czech Republic
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia
  • Univerzita Karlova v Praze
  • Grantová Agentura České Republiky

Zitieren

APA

Chan, W. L., Olbrich, S., Jiang, X., Zhang, H., Ip, C. T., & Brunovsky, M. (2025). Subanesthetic ketamine alters EEG signal complexity: Implications for treatment stratification in depression. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.119477

Vancouver

Chan WL, Olbrich S, Jiang X, Zhang H, Ip CT, Brunovsky M. Subanesthetic ketamine alters EEG signal complexity: Implications for treatment stratification in depression. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.119477

BibTeX
@article{Chan2025,
  author = {Chan, Weng-Lam and Olbrich, Sebastian and Jiang, Xinwen and Zhang, Haoyun and Ip, Cheng-Teng and Brunovsky, Martin},
  title = {Subanesthetic ketamine alters EEG signal complexity: Implications for treatment stratification in depression},
  journal = {Journal of Affective Disorders},
  year = {2025},
  doi = {10.1016/j.jad.2025.119477}
}
Kostenlos starten →